EDGAR Filing Documents for 0001654954-17-010766

Form 8-K - Current report:

SEC Accession No. 0001654954-17-010766

Filing Date

2017-11-16

Accepted

2017-11-16 08:00:42

Documents

Period of Report

2017-11-16

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	gtbp_8k.htm	8-K	25899
2	MATERIAL CONTRACTS	gtbp_ex101.htm	EX-10.1	81758
3	ADDITIONAL EXHIBITS	gtbp_ex991.htm	EX-99.1	12699
	Complete submission text file	0001654954-17-010766.txt		121892

Mailing Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602

Business Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602 (800) 304-9888

GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)